Patent ID: 8932592
Filing Date: 2015-01-13
Classification: A61P,C07K,Y10S

Abstract:
1. An isolated anti-fractalkine antibody or fractalkine-binding fragment thereof, wherein the antibody or fragment thereof comprises: (a) a CDR-H1 consisting of the amino acid sequence of SEQ ID NO: 28; (b) a CDR-H2 consisting of the amino acid sequence of SEQ ID NO: 29; (c) a CDR-H3 consisting of the amino acid sequence of SEQ ID NO: 30; (d) a CDR-L1 consisting of the amino acid sequence of SEQ ID NO: 31; (e) a CDR-L2 consisting of the amino acid sequence of SEQ ID NO: 32; and (f) a CDR-L3 consisting of the amino acid sequence of SEQ ID NO: 33.